Combating cardiovascular disease, diabetes and rare diseases
Cardiovascular disease and diabetes are two of the major causes of mortality and ill health in Europe. More than 19 million people in the European Union suffer from diabetes (and many more if undiagnosed people are considered), whilst cardiovascular disease accounts for more that 40% of all deaths in Europe
Whilst rare diseases, by definition, affect far fewer people, they can be life-threatening and chronically debilitating conditions and, as yet, few drugs have been developed to treat them. The large variety of these diseases many of which have a genetic basis means that the research effort in Europe is fragmented. Greater focus should help to realise the benefits of pooling Europe's research resources to tackle such diseases.
In order to increase understanding of these three major types of disease, support will be given for genomic approaches which elucidate their genetic and molecular pathology, and for the translation of knowledge into improved prevention, diagnosis and treatment.
Work Programme with research topics for currently open call(s)
Commission contacts for this area:
Catherine Berens: Contact Form
Elmar Nimmesgern: Contact Form
Nathalie Vercruysse: Contact Form
Cardiovascular disease: FP6 projects
Diabetes: EU funding of diabetes/obesity research under Framework Programmes 5 and 6
Rare diseases: FP6 rare diseases projects.
- Cardiovascular Disease Research - EU support in the Sixth Framework Programme (2002-2006) (Booklet). PDF
- Cardiovascular Disease (CVD) Research - EU support in the 6th Framework Programme (2002-2006) (Flyer). PDF
- The Future of Cardiovascular Research in Europe, The European Commission Conference, Brussels, 19 March 2004 - Proceedings. PDF
- Catalogue of projects funded in the field of cardiovascular disease research in Fifth Framework Programme (1998-2002), download from CORDIS Quality of Life Publications
- 30 March 2007: Workshop "NANODIAB", Brussels, Belgium
This workshop brought together leading scientists from the fields of diabetes, nanostructured biomaterials research, and the Juvenile Diabetes Research Foundation (JRDF) with the Commissions Officers from Unit F2 and G3 of DG Research with responsibilities for health and nanotechnology in FP7.
The purpose of the workshop was to review a) progress in FP6 research in both fields; b) research directions stimulated by the first calls of FP7 by Themes -1 (Health) and -4 (Nanosciences, Nanotechnologies, Material & New Production and c) how increased collaboration by scientists from both fields could be stimulated to provide better treatment options for sufferers of both diseases.
Download the highlights of the event (PDF)
- Catalogue of Community funded projects in the field of diabetes research in FP5 (Quality of Life and Management of Living Resources Programme - 1998-2002) (Download in PDF)
- Diabetes: New insights into an age-old enemy, PDF leaflet
- Diabetes: EU-JDRF (Juvenile Diabetes Research Foundation) Workshop on Diabetes, 2 December 2005, European Parliament Brussels. PDF
- Diabetes Conference : Europe Rising to the Research Challenge, 12 November 2004, European Parliament Brussels. PDF
- Catalogue of Community funded projects in the field of diabetes research in FP5 (Quality of Life and Management of Living Resources Programme - 1998-2002) , PDF
- Rare Diseases: Concentrating European Research for the Few, PDF leaflet
- Catalogue of projects funded in the field of rare diseases research in Fifth Framework Programme (1998-2002), PDF
Activities in Diabetes
Activities in Rare Diseases :